Skip to main content
RLMD logo

RLMD · Relmada Therapeutics, Inc. · Proposed Sales

Track RLMD — free
$4.21 +0.05 (+1.20%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$449.19M
Shares
106.69M
Volume · Nov 13 1.74M Avg daily vol (3M) 1.35M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2024-02-20 O'Gorman Cedric 74,999
Showing 1–1 of 1 filings
Key facts CIK 1553643 CUSIP 75955J402 13F (30d) 91 filings 78 filers Visit website Investor relations